-
-
7 . Periodical
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial
- 저자
- by Li, Grace; Cappuccini, Federica; Marchevsky, Natalie G; Aley, Parvinder K; Aley, Robert, et al.
- 소스
- The Lancet; June 2022, Vol. 399 Issue: 10342 p2212-2225, 14p
-